Cargando…

P574: DIAGNOSIS AND TREATMENT OF T/MYELOID MIXED PHENOTYPE ACUTE LEUKAEMIA (T/M-MPAL)- A UK SINGLE CENTRE EXPERIENCE

Detalles Bibliográficos
Autores principales:	Abusalim, Enas, Vitsaras, Evan, Orfinada, Karen, Robert, Baker, Nacheva, Elisabeth, Wilson, Andrew, O’nions, Jenny, Rajeev, Gupta, Xu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429566/ http://dx.doi.org/10.1097/01.HS9.0000969200.11580.ad

Ejemplares similares

Mixed-phenotype acute leukemia (MPAL) and beyond
por: Kim, Hee-Je
Publicado: (2016)

Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)
por: Klocke, Heather, et al.
Publicado: (2020)

A paradigm shift: lineage switch from T-ALL to B/myeloid MPAL
por: Rath, Asish, et al.
Publicado: (2021)

Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
por: Virgili, Anna, et al.
Publicado: (2010)

Memorandum 574
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1996)

Unidad médica de primer contacto D.I.F. mpal. Coatepec, Ver /
por: Rios Garces, Martín
Publicado: (1992)

Ampliación del cementerio y diseño de velatorio mpal.en Banderilla, Ver.
por: Jiménez Zamora, Abigail
Publicado: (2017)

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)

Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000–2018: population-based cohort study
por: McKechnie, Douglas G. J., et al.
Publicado: (2023)

P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS
por: Mehta, Priyanka, et al.
Publicado: (2023)

574 The Impact of Age on Wound Healing Progression in Burns
por: Pignet, Anna-Lisa, et al.
Publicado: (2023)

Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
por: Tembhare, Prashant, et al.
Publicado: (2023)

Transgender identity in young people and adults recorded in UK primary care electronic patient records: retrospective, dynamic, cohort study
por: McKechnie, Douglas Gordon John, et al.
Publicado: (2023)

The Measurement of Adult Pathological Demand Avoidance Traits
por: Egan, Vincent, et al.
Publicado: (2018)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
por: Russell-Smith, T. Alexander, et al.
Publicado: (2021)

CD47 expression in acute myeloid leukemia varies according to genotype
por: Marra, Andrea, et al.
Publicado: (2023)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Unilateral nasal obstruction: a rare presentation of acute myeloid leukaemia
por: Kelly, Mairead, et al.
Publicado: (2021)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
por: Hanekamp, Diana, et al.
Publicado: (2020)

P1389: A NOVEL AND SUCCESSFUL CD7-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR REFRACTORY/RELAPSED MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)
por: Zhang, Xian, et al.
Publicado: (2023)

574 Want some s’more? The hidden risks of marshmallows
por: Ghini, Francesca, et al.
Publicado: (2022)

Human leukaemia: recent tissue culture studies on the nature of myeloid leukaemia.
por: Metcalf, D.
Publicado: (1973)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

How do Parents Manage Irritability, Challenging Behaviour, Non-Compliance and Anxiety in Children with Autism Spectrum Disorders? A Meta-Synthesis
por: O’Nions, Elizabeth, et al.
Publicado: (2017)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

574. Late Diagnosis of HIV in South Carolina: Prevalence, Cause, and Consequences
por: Hossain, Akhtar, et al.
Publicado: (2018)

SUN-574 A1AT: Novel Inhibitor of Active PCSK9
por: Melendez, Quantil, et al.
Publicado: (2020)

ODP574 Characteristics of Grave's Disease Among Children and Adolescents in KSA
por: Alradadi, Rasha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pn6r5ak7cvpb6h7dif0s1llqco